Indolent non-Hodgkin lymphoma (NHL) treatment in 1 Oncology clinic in København
1 clinic specializing in Oncology providing treatment of Indolent non-Hodgkin lymphoma (NHL) Indolent non-Hodgkin lymphoma (NHL) is a slow-growing form of lymphoma characterized by abnormal lymphocyte proliferation. It tends to have a more chronic course with milder symptoms compared to aggressive NHL. disease in København.
Besides this clinic there are 2 Oncology clinics in Denmark.
Such diseases are treated by Rigshospitalet: Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML), Adrenoleukodystrophy, Aggressive non-Hodgkin lymphoma (NHL), Amyloidosis, and others.
Sorted by:
Relevance
Rating
Relevance
Prices for popular procedures:
2 nearby similar clinics in Denmark
Perhaps you should consider 2 more clinics we have found nearby basing on your Location, Disease filters applied.
Prices for popular procedures:
Århus, Denmark
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Neurosurgery, Spine surgery, Orthopedic surgery, Oncology
Aarhus University Hospital offers specialised treatment to citizens in the Central Denmark Region and other regions in Denmark. Aarhus University Hospital is the local hospital
read more
Prices for popular procedures:
Aalborg, Denmark
Specializations: Cardiac surgery, Vascular surgery, Thoracic surgery, Neurosurgery, Spine surgery, Orthopedic surgery, Oncology
Aalborg University Hospital is the largest hospital in the North Denmark Region. It is also northern Jutland's largest employer, with approximately 6,000 employees. The hospital
read more
Countries with the highest number of clinics treating the diseases:
Indolent non-Hodgkin lymphoma (NHL):
worldwide
760 clinics
Brazil
48 clinics
India
45 clinics
Germany
36 clinics
Mexico
32 clinics
Colombia
29 clinics
Related procedures:
Procedures are likely to be used for Indolent non-Hodgkin lymphoma (NHL) treatment:
Allogeneic bone marrow transplantation (BMT),
Autologous bone marrow transplantation (BMT),
Chemotherapy for lymphoma,
Chimeric antigen receptor (CAR) T-cell therapy,
and
Cord blood stem cell transplantation
.